(MedPage Today) -- Favorable results with dimethyl fumarate (BG-12) reported earlier at conferences have now passed the test of peer review, boosting the drug's candidacy for the Next Big Thing in multiple sclerosis. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment